- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AHIP Statement on the Administration’s National Effort Calling for COVID-19 Survivors to Donate Plasma
Coronavirus disease 2019 (COVID-19) has presented new challenges every day, as well as new opportunities.
WASHINGTON, D.C. – Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP), issued this statement following the Administration’s announcement of a nationwide effort to encourage everyone who has recovered from coronavirus disease 2019 (COVID-19) and has been symptom-free for at least 14 days to donate plasma. This plasma will be used to help other patients recover from COVID-19.
“Since COVID-19 first impacted our nation, we’ve seen ‘ordinary’ Americans do extraordinary things. Seemingly overnight, our country’s doctors, nurses, hospital personnel, emergency medical services workers, and public health leaders transformed into heroes, putting the health of the patients and communities they serve ahead of their own and in spite of very serious risks to themselves and their families. Our truckers, grocers, and manufacturers are working overtime to keep America supplied and fed. Health insurance providers are working with partners across our communities to ensure access to much-needed care and services. And millions of Americans are checking on friends, neighbors, and loved ones to offer support or a helping hand."
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More
